Published in Sleep on March 01, 2005
REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci (2010) 2.46
Dreamlike mentations during sleepwalking and sleep terrors in adults. Sleep (2009) 1.76
Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder. Sleep (2008) 1.49
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Diagnosis of REM sleep behavior disorder by video-polysomnographic study: is one night enough? Sleep (2008) 1.23
Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy. Sleep (2008) 1.22
REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease. Curr Neurol Neurosci Rep (2012) 1.19
Sleep in Wilson's disease: Questionnaire based study. Ann Indian Acad Neurol (2011) 1.14
Parasomnias: an updated review. Neurotherapeutics (2012) 0.98
REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management. Drugs Aging (2010) 0.93
Diagnostic tools for REM sleep behavior disorder. Sleep Med Rev (2011) 0.82
REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep (2007) 0.81
Idiopathic REM sleep behavior disorder as a long-term predictor of neurodegenerative disorders. EPMA J (2011) 0.80
Sleep Disorders in Atypical Parkinsonism. Mov Disord Clin Pract (2014) 0.79
Therapeutic options for nocturnal problems in Parkinson's disease and atypical parkinsonian disorders. J Neural Transm (Vienna) (2014) 0.78
Parkinson's disease and sleep/wake disturbances. Parkinsons Dis (2012) 0.78
Rapid eye movement sleep behavior disorder. Curr Opin Neurobiol (2013) 0.77
Sleep in genetically confirmed pantothenate kinase-associated neurodegeneration: a video-polysomnographic study. Parkinsons Dis (2010) 0.77
Loss of rapid eye movement sleep atonia in patients with REM sleep behavioral disorder, narcolepsy, and isolated loss of REM atonia. J Clin Sleep Med (2013) 0.77
Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson's disease. BMC Neurol (2014) 0.76
RBD and Neurodegenerative Diseases. Mol Neurobiol (2016) 0.76
Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy. Parkinsons Dis (2016) 0.75
Altered sleep and EEG power in the P301S Tau transgenic mouse model. Ann Clin Transl Neurol (2017) 0.75
Progressive supranuclear palsy: progression and survival. J Neurol (2015) 0.75
Rest-activity rhythm disruption in progressive supranuclear palsy. Sleep Med (2016) 0.75
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry (2013) 5.89
Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med (2005) 3.88
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci (2010) 3.05
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol (2007) 2.61
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet (2010) 2.21
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med (2009) 2.09
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. Neurology (2013) 2.06
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry (2012) 1.94
A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data. Neuroimage (2006) 1.93
Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry (2009) 1.92
Myoclonus-dystonia: an update. Mov Disord (2009) 1.90
Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol (2009) 1.87
Reduced breathing variability as a predictor of unsuccessful patient separation from mechanical ventilation. Crit Care Med (2006) 1.81
Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to ε-sarcoglycan mutations: a pilot study. Arch Neurol (2011) 1.79
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. J Neurosurg (2009) 1.74
Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Crit Rev Food Sci Nutr (2008) 1.73
Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol (2007) 1.72
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain (2008) 1.72
Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome. Brain (2012) 1.69
Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain (2003) 1.68
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum Mol Genet (2010) 1.67
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A (2007) 1.66
Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity. Mov Disord (2012) 1.64
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol (2012) 1.61
Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord (2007) 1.58
Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch Neurol (2002) 1.54
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord (2006) 1.54
G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol (2005) 1.54
Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits. Lancet Neurol (2013) 1.52
Restoration of normal motor control in Parkinson's disease during REM sleep. Brain (2007) 1.47
Dyspnea as a noxious sensation: inspiratory threshold loading may trigger diffuse noxious inhibitory controls in humans. J Neurophysiol (2006) 1.47
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain (2009) 1.44
How much phenotypic variation can be attributed to parkin genotype? Ann Neurol (2003) 1.44
Myoclonus or tremor in orthostatism: an under-recognized cause of unsteadiness in Parkinson's disease. Mov Disord (2007) 1.42
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain (2006) 1.41
TENS for the treatment of propriospinal myoclonus. Mov Disord (2008) 1.41
FXTAS: new insights and the need for revised diagnostic criteria. Neurology (2012) 1.39
Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method. J Neurosurg (2003) 1.35
Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep (2005) 1.34
Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33
Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol (2008) 1.32
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain (2010) 1.30
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study. Brain (2004) 1.27
Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Arch Neurol (2004) 1.27
The anatomical basis of dystonia: current view using neuroimaging. Mov Disord (2013) 1.27
Sleep and alertness in children with attention-deficit/hyperactivity disorder: a systematic review of the literature. Sleep (2006) 1.24
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol (2004) 1.24
Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain (2004) 1.22
Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry (2010) 1.21
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One (2009) 1.19
Foot, hand, face and eye representation in the human striatum. Cereb Cortex (2003) 1.17
Dystonia rating scales: critique and recommendations. Mov Disord (2013) 1.17
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem (2003) 1.16
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale. PLoS One (2011) 1.15
Compulsions, Parkinson's disease, and stimulation. Lancet (2002) 1.15
Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol (2008) 1.14
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord (2012) 1.14
Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet (2003) 1.13
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J Neurochem (2002) 1.13
Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis (2012) 1.12
Eating disorder and metabolism in narcoleptic patients. Sleep (2007) 1.11
Association study between iron-related genes polymorphisms and Parkinson's disease. J Neurol (2002) 1.09
Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Brain (2010) 1.09
Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol (2009) 1.07
Defective cerebellar control of cortical plasticity in writer's cramp. Brain (2013) 1.06
Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study. Brain (2004) 1.06
Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord (2006) 1.06
RAD51 deficiency disrupts the corticospinal lateralization of motor control. Brain (2013) 1.06
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord (2009) 1.06
Normal and pathological gait: what we learn from Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.04
RAD51 haploinsufficiency causes congenital mirror movements in humans. Am J Hum Genet (2012) 1.04
Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med (2008) 1.04
[123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism. J Neurol Sci (2008) 1.04
Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease. Arch Neurol (2003) 1.03
Sleep disturbances and serum ferritin levels in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2009) 1.03
Comparison of bedside measurement of cardiac output with the thermodilution method and the Fick method in mechanically ventilated patients. Crit Care (2002) 1.03
Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch Neurol (2004) 1.02
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain (2013) 1.02
Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord (2014) 1.02
PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology (2012) 0.99
Micrographia secondary to lenticular lesions. Mov Disord (2002) 0.99
Motor execution and imagination networks in post-stroke dystonia. Neuroreport (2004) 0.99
Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson's disease. Brain Cogn (2005) 0.98
Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Disord (2007) 0.98
Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both? PLoS One (2010) 0.98
Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature. Expert Rev Neurother (2012) 0.98
Are parkin patients particularly suited for deep-brain stimulation? Mov Disord (2008) 0.97
LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. Arch Neurol (2007) 0.97